Merck Colombia, Janssen-Cilag SA, Novartis, Pfizer SA and AstraZeneca Colombia SA. E Gotuzzo has been a consultant to Pfizer and has received research funds from Johnson & Johnson. M Guzman-Blanco ...

AstraZeneca still trades at a premium valuation, but several factors limit its upside potential in the next visible period. There are three negative takeaways from China. IRA could also ...

HUTCHMED is now set to gain a milestone payment from AstraZeneca. Progression-free survival (PFS) was the primary endpoint as evaluated by investigators. Secondary endpoints include PFS by independent ...

UK-based pharmaceutical giant AstraZeneca has announced plans to restructure its biopharma unit to concentrate on next-generation therapeutics. “In the Biopharmaceutical Business Unit, we are now ...

IT worker can continue legal battle against pharmaceutical giant after judge rules that impact of skin condition makes him a disabled person An IT worker has won a legal battle to sue AstraZeneca ...

AstraZeneca India has laid off over 125 employees in its biopharmaceutical business unit, including senior managers and sales executives. The job cuts are part of a strategic restructuring due to loss ...

marketed as Lynparza by AstraZeneca, or trastuzumab deruxtecan, marketed by AstraZeneca and Daiichi Sankyo as Enhertu. Eisbach aims to initiate the Phase II portion of this study within Q2 2025. The ...

LONDON, Dec 24 (Reuters) - AstraZeneca (AZN.L), opens new tab has voluntarily withdrawn its marketing authorisation application with the EU's medicines regulator for its experimental precision ...

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of AstraZeneca PLC (NASDAQ ...

Haga clic aquí para leer esta historia en español. VALLE DEL CAUCA, Colombia — From the side of an old highway that cuts through the Andean foothills, Dora Alicia Londoño’s home looks ...

"It's appalling the way AstraZeneca has been treated. I wouldn't blame them if they were thoroughly fed up and decided to bow out of the Covid vaccine business." That was the view from one of the ...